Kensington, CT, United States of America

Paul P Tamburini

This inventor holds 29 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Complement Biology. Top assignees: Alexion Pharmaceuticals, Inc., Bayer Corporation, Aerovance, Inc.. Active years: 1994-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul P Tamburini. Retrieved from https://idiyas.com/inventor/paul-p-tamburini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 15)

% Patents Active = 89.7

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 14)

Average Co-Inventor Count = 3.9

ph-index = 11

Forward Citations = 395(Granted Patents)

Company Filing History:

22 out of 199

Alexion Pharmaceuticals, Inc.

Years Active: 1994-2025

Loading Chart...

Areas of Expertise:

Anti-C5 Antibodies

Complement Component C5

Pharmacokinetics

Atypical Hemolytic Uremic Syndrome

Fusion Proteins

Polypeptides

Nucleic Acids

Complement-Associated Disorders

Anti-C5A Antibodies

Diagnostic Assay

HIV Inhibitors

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497445 - MONOVALENT ANTI-PROPERDIN ANTIBODIES AND ANTIBODY FRAGMENTS (2025-12-16),

2. 12221473 - Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof (2025-02-11),

3. 11498960 - Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof (2022-11-15),

4. 11434280 - Anti-C5 antibodies having improved pharmacokinetics (2022-09-06),

5. 11407821 - Anti-C5A antibodies (2022-08-09),

6. 11198725 - Monovalent anti-properdin antibodies and antibody fragments (2021-12-14),

7. 10584164 - Methods of treating atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria with anti-C5 antibodies (2020-03-10),

8. 10450370 - Anti-C5a antibodies (2019-10-22),

9. 10227400 - Methods of treating atypical hemolytic uremic syndrome with anti-C5 antibodies (2019-03-12),

10. 9963503 - Methods of producing anti-C5a antibodies (2018-05-08),

11. 9803007 - Anti-C5 antibodies having improved pharmacokinetics (2017-10-31),

12. 9663574 - Anti-C5 antibodies having improved pharmacokinetics (2017-05-30),

13. 9469690 - Methods of treating complement-associated disorders with anti-C5a antibodies (2016-10-18),

14. 9434784 - Nucleic acids encodng anti-C5A antibodies (2016-09-06),

15. 9371378 - Anti-C5a antibodies (2016-06-21),

Title: The Innovative Journey of Paul P Tamburini

Introduction: Paul P Tamburini, a talented inventor hailing from Kensington, CT (US), has made significant contributions to the field of innovations with his creative mind and dedication.

Latest Patents: Paul P Tamburini holds several patents in various technological areas, showcasing his versatility and expertise in inventing cutting-edge solutions to real-world problems.

Career Highlights: Throughout his illustrious career, Paul P Tamburini has demonstrated a keen eye for identifying gaps in the market and developing unique inventions to fill those voids. His innovative spirit has led to the creation of groundbreaking technologies that have revolutionized industries.

Collaborations: Paul P Tamburini has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Paul P Tamburini stands as a beacon of innovation in the world of inventors, continuously pushing the boundaries of what is possible through his groundbreaking creations. His passion for innovation and commitment to excellence serve as an inspiration to aspiring inventors worldwide.

Profile summary based on public USPTO records.